Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid

Stopped PI did not pursue this study; this study was not IRB-approved and never started.

Conditions

• Bullous Pemphigoid

Interventions

• DRUG: Rituximab combined with Omalizumab

Sponsor

University of California, Davis